Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Hubert Schrezenmeier

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Anatomy

Procedures

Concepts & Ideas

Physiology

Lymphocyte Activation

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Bacher Ulrike; Klyuchnikov Evgeny; Zabelina Tatjana; Ottinger Hellmut; Beelen Dietrich W; Schrezenmeier Hubert; Ehninger Gerhard; Müller Carlheinz; Berger Jürgen; Suttorp Meinolf; Kolb Hans-Jochem; Kröger Nicolaus; Zander Axel R
The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia--a report from the German Registry covering the period from 1998 to 2004.
Lösler Susan; Schlief Sarah; Kneifel Christiane; Thiel Eckhard; Schrezenmeier Hubert; Rojewski Markus T
Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system.
Lotfi Ramin; Herzog Gloria Isabelle; DeMarco Richard Anthony; Beer-Stolz Donna; Lee James Joseph; Rubartelli Anna; Schrezenmeier Hubert; Lotze Michael Thomas
Eosinophils oxidize damage-associated molecular pattern molecules derived from stressed cells.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Hubert Schrezenmeier (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Bacher Ulrike; Klyuchnikov Evgeny; Zabelina Tatjana; Ottinger Hellmut; Beelen Dietrich W; Schrezenmeier Hubert; Ehninger Gerhard; Müller Carlheinz; Berger Jürgen; Suttorp Meinolf; Kolb Hans-Jochem; Kröger Nicolaus; Zander Axel R
The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia--a report from the German Registry covering the period from 1998 to 2004.
Annals of hematology 2009;88(12):1237-47.
2009: Lösler Susan; Schlief Sarah; Kneifel Christiane; Thiel Eckhard; Schrezenmeier Hubert; Rojewski Markus T
Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system.
Annals of hematology 2009;88(11):1047-58.
2009: Lotfi Ramin; Herzog Gloria Isabelle; DeMarco Richard Anthony; Beer-Stolz Donna; Lee James Joseph; Rubartelli Anna; Schrezenmeier Hubert; Lotze Michael Thomas
Eosinophils oxidize damage-associated molecular pattern molecules derived from stressed cells.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(8):5023-31.
2009: Hirv K; Bloch K; Fischer M; Einsiedler B; Schrezenmeier H; Mytilineos J
Prediction of duration and success rate of unrelated hematopoietic stem cell donor searches based on the patient's HLA-DRB1 allele and DRB1-DQB1 haplotype frequencies.
Bone marrow transplantation 2009;44(7):433-40.
2009: Breitinger Heike H; Rojewski Markus T; Schrezenmeier Hubert
Antibodies to glycosylphosphatidyl-inositol anchored proteins (GPI-AP) in antithymocyte and antilymphocyte globulin: possible role for the expansion of GPI-AP deficient cells in aplastic anemia.
Annals of hematology 2009;88(9):889-95.
2009: Lawler Mark; McCann Shaun R; Marsh Judith C W; Ljungman Per; Hows Jill; Vandenberghe Elisabeth; O'Riordan Joan; Locasciulli Anna; Socié Gérard; Kelly Alan; Schrezenmeier Hubert; Marin Pedro; Tichelli André; Passweg Jakob R; Dickenson Anne; Ryan Jacqueline; Bacigalupo Andrea;
Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.
British journal of haematology 2009;144(6):933-45.
2009: Young Neal S; Meyers Gabrielle; Schrezenmeier Hubert; Hillmen Peter; Hill Anita
The management of paroxysmal nocturnal hemoglobinuria: recent advances in diagnosis and treatment and new hope for patients.
Seminars in hematology 2009;46(1 Suppl 1):S1-S16.
2009: Lotfi Ramin; Schrezenmeier Hubert; Lotze Michael Thomas
Immunotherapy for cancer: promoting innate immunity.
Frontiers in bioscience : a journal and virtual library 2009;14():818-32.
2008: Dausend Julia; Musyanovych Anna; Dass Martin; Walther Paul; Schrezenmeier Hubert; Landfester Katharina; Mailänder Volker
Uptake mechanism of oppositely charged fluorescent nanoparticles in HeLa cells.
Macromolecular bioscience 2008;8(12):1135-43.
2008: Körper Sixten; Hütter Gero; Blau Wolfgang; Blau Olga; Schrezenmeier Hubert; Knauf Wolfgang; Thiel Eckhard
Successful treatment of partial graft failure after matched unrelated donor stem cell transplantation by a combination of ancestim (stem cell factor) and granulocyte colony stimulating factor in a patient with heavily pre-treated chronic lymphocytic leukemia.
Leukemia & lymphoma 2008;49(10):2015-7.
2008: Mailänder Volker; Lorenz Myriam Ricarda; Holzapfel Verena; Musyanovych Anna; Fuchs Karin; Wiesneth Markus; Walther Paul; Landfester Katharina; Schrezenmeier Hubert
Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2008;10(3):138-46.
2008: Brodsky Robert A; Young Neal S; Antonioli Elisabetta; Risitano Antonio M; Schrezenmeier Hubert; Schubert Jörg; Gaya Anna; Coyle Luke; de Castro Carlos; Fu Chieh-Lin; Maciejewski Jaroslaw P; Bessler Monica; Kroon Henk-André; Rother Russell P; Hillmen Peter
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria.
Blood 2008;111(4):1840-7.
2008: Viollier R; Socié G; Tichelli A; Bacigalupo A; Korthof E T; Marsh J; Cornish J; Ljungman P; Oneto R; Békássy A N; Fuehrer M; Maury S; Schrezenmeier H; van Lint M T; Wojcik D; Locasciulli A; Passweg J R
Recent improvement in outcome of unrelated donor transplantation for aplastic anemia.
Bone marrow transplantation 2008;41(1):45-50.
2007: Hillmen Peter; Muus Petra; Dührsen Ulrich; Risitano Antonio M; Schubert Jörg; Luzzatto Lucio; Schrezenmeier Hubert; Szer Jeffrey; Brodsky Robert A; Hill Anita; Socié Gerard; Bessler Monica; Rollins Scott A; Bell Leonard; Rother Russell P; Young Neal S
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria.
Blood 2007;110(12):4123-8.
2007: Schrezenmeier Hubert; Passweg Jakob R; Marsh Judith C W; Bacigalupo Andrea; Bredeson Christopher N; Bullorsky Eduardo; Camitta Bruce M; Champlin Richard E; Gale Robert Peter; Fuhrer Monika; Klein John P; Locasciulli Anna; Oneto Rosi; Schattenberg Antonius V M B; Socie Gerard; Eapen Mary
Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia.
Blood 2007;110(4):1397-400.
2007: Wiehe Juliane M; Ponsaerts Peter; Rojewski Markus T; Homann Joerg M; Greiner Jochen; Kronawitter Desiree; Schrezenmeier Hubert; Hombach Vinzenz; Wiesneth Markus; Zimmermann Oliver; Torzewski Jan
mRNA-mediated gene delivery into human progenitor cells promotes highly efficient protein expression.
Journal of cellular and molecular medicine 2007;11(3):521-30.
2007: Schrezenmeier Hubert; Walther-Wenke Gabriele; Müller Thomas H; Weinauer Franz; Younis Adelheid; Holland-Letz Tim; Geis Gabriele; Asmus Jens; Bauerfeind Ursula; Burkhart Jürgen; Deitenbeck Robert; Förstemann Elisabeth; Gebauer Wolfgang; Höchsmann Britta; Karakassopoulos Apostolos; Liebscher Ute-Maja; Sänger Werner; Schmidt Michael; Schunter Friedrich; Sireis Walid; Seifried Erhard
Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets.
Transfusion 2007;47(4):644-52.
2007: Socie Gerard; Mary Jean-Yves; Schrezenmeier Hubert; Marsh Judith; Bacigalupo Andrea; Locasciulli Anna; Fuehrer Monica; Bekassy Albert; Tichelli Andre; Passweg Jakob
Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT).
Blood 2007;109(7):2794-6.
2007: Locasciulli Anna; Oneto Rosi; Bacigalupo Andrea; Socié Gerard; Korthof Elisabeth; Bekassy Albert; Schrezenmeier Hubert; Passweg Jakob; Führer MoniKa;
Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).
Haematologica 2007;92(1):11-8.
2007: McCann S; Passweg J; Bacigalupo A; Locasciulli A; Locatelli F; Ryan J; Schrezenmeier H; Lawler M
The influence of cyclosporin alone, or cyclosporin and methotrexate, on the incidence of mixed haematopoietic chimaerism following allogeneic sibling bone marrow transplantation for severe aplastic anaemia.
Bone marrow transplantation 2007;39(2):109-14.
2006: Flegel Willy A; Eicher Nicole I; Doescher Andrea; Hustinx Hein; Gowland Peter; Mansouri Taleghani Behrouz; Petershofen Eduard K; Bauerfeind Ursula; Ernst Manfred; von Zabern Ingeborg; Schrezenmeier Hubert; Wagner Franz F
In-frame triplet deletions in RHD alter the D antigen phenotype.
Transfusion 2006;46(12):2156-61.
2006: Hillmen Peter; Young Neal S; Schubert Jörg; Brodsky Robert A; Socié Gerard; Muus Petra; Röth Alexander; Szer Jeffrey; Elebute Modupe O; Nakamura Ryotaro; Browne Paul; Risitano Antonio M; Hill Anita; Schrezenmeier Hubert; Fu Chieh-Lin; Maciejewski Jaroslaw; Rollins Scott A; Mojcik Christopher F; Rother Russell P; Luzzatto Lucio
The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.
The New England journal of medicine 2006;355(12):1233-43.
2006: Rojewski Markus T; Schrezenmeier Hubert; Flegel Willy A
Tissue distribution of blood group membrane proteins beyond red cells: evidence from cDNA libraries.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2006;35(1):71-82.
2006: Stern Martin; Passweg Jakob R; Locasciulli Anna; Socié Gerard; Schrezenmeier Hubert; Békássy Albert N; Fuehrer Monica; Hows Jill; Korthof Elisabeth T; McCann Shaun; Tichelli André; Zoumbos Nicholas C; Marsh Judith C W; Bacigalupo Andrea; Gratwohl Alois;
Influence of donor/recipient sex matching on outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia.
Transplantation 2006;82(2):218-26.
2006: Lorenz Myriam Ricarda; Holzapfel Verena; Musyanovych Anna; Nothelfer Karin; Walther Paul; Frank Hendrik; Landfester Katharina; Schrezenmeier Hubert; Mailänder Volker
Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells.
Biomaterials 2006;27(14):2820-8.
2006: Passweg J R; Pérez W S; Eapen M; Camitta B M; Gluckman E; Hinterberger W; Hows J M; Marsh J C W; Pasquini R; Schrezenmeier H; Socié G; Zhang M-J; Bredeson C
Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia.
Bone marrow transplantation 2006;37(7):641-9.
2005: Audebert Heinrich J; Planck Johannes; Eisenburg Markus; Schrezenmeier Hubert; Haberl Roman L
Cerebral ischemic infarction in paroxysmal nocturnal hemoglobinuria report of 2 cases and updated review of 7 previously published patients.
Journal of neurology 2005;252(11):1379-86.
2005: Beier Fabian; Balabanov Stefan; Buckley Tom; Dietz Klaus; Hartmann Ulrike; Rojewski Markus; Kanz Lothar; Schrezenmeier Hubert; Brümmendorf Tim H
Accelerated telomere shortening in glycosylphosphatidylinositol (GPI)-negative compared with GPI-positive granulocytes from patients with paroxysmal nocturnal hemoglobinuria (PNH) detected by proaerolysin flow-FISH.
Blood 2005;106(2):531-3.
2005: Mohr Andrea; Zwacka Ralf Michael; Jarmy Gergely; Büneker Chirlei; Schrezenmeier Hubert; Döhner Konstanze; Beltinger Christian; Wiesneth Markus; Debatin Klaus-Michael; Stahnke Karsten
Caspase-8L expression protects CD34+ hematopoietic progenitor cells and leukemic cells from CD95-mediated apoptosis.
Oncogene 2005;24(14):2421-9.
2004: Rojewski Markus Thomas; Körper Sixten; Schrezenmeier Hubert
Arsenic trioxide therapy in acute promyelocytic leukemia and beyond: from bench to bedside.
Leukemia & lymphoma 2004;45(12):2387-401.
2004: Nolte Florian; Friedrich Oliver; Rojewski Markus; Fink Rainer H A; Schrezenmeier Hubert; Körper Sixten
Depolarisation of the plasma membrane in the arsenic trioxide (As2O3)-and anti-CD95-induced apoptosis in myeloid cells.
FEBS letters 2004;578(1-2):85-9.
2004: Stadler M; Germing U; Kliche K-O; Josten K M; Kuse R; Hofmann W-K; Schrezenmeier H; Novotny J; Anders O; Eimermacher H; Verbeek W; Kreipe H-H; Heimpel H; Aul C; Ganser A
A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(3):460-5.
2004: Seifried Carola; Weber Marijke; Bialleck Heike; Seifried Erhard; Schrezenmeier Hubert; Roth W Kurt
High prevalence of GBV-C/HGV among relatives of GBV-C/HGV-positive blood donors in blood recipients and in patients with aplastic anemia.
Transfusion 2004;44(2):268-74.
2004: Rojewski Markus Thomas; Körper Sixten; Thiel Eckhard; Schrezenmeier Hubert
Arsenic trioxide-induced apoptosis is independent of CD95 in lymphatic cell lines.
Oncology reports 2004;11(2):509-13.
2004: Rojewski Markus T; Körper Sixten; Thiel Eckhard; Schrezenmeier Hubert
Depolarization of mitochondria and activation of caspases are common features of arsenic(III)-induced apoptosis in myelogenic and lymphatic cell lines.
Chemical research in toxicology 2004;17(1):119-28.
2004: Körper Sixten; Nolte Florian; Thiel Eckhard; Schrezenmeier Hubert; Rojewski Markus T
The role of mitochondrial targeting in arsenic trioxide-induced apoptosis in myeloid cell lines.
British journal of haematology 2004;124(2):186-9.
2003: Körper Sixten; Nolte Florian; Rojewski Markus Thomas; Thiel Eckhard; Schrezenmeier Hubert
The K+ channel openers diazoxide and NS1619 induce depolarization of mitochondria and have differential effects on cell Ca2+ in CD34+ cell line KG-1a.
Experimental hematology 2003;31(9):815-23.
2003: Mortazavi Yousef; Merk Bruno; McIntosh Jenny; Marsh Judith C W; Schrezenmeier Hubert; Rutherford Tim R;
The spectrum of PIG-A gene mutations in aplastic anemia/paroxysmal nocturnal hemoglobinuria (AA/PNH): a high incidence of multiple mutations and evidence of a mutational hot spot.
Blood 2003;101(7):2833-41.
2003: Frickhofen Norbert; Heimpel Hermann; Kaltwasser Joachim P; Schrezenmeier Hubert;
Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia.
Blood 2003;101(4):1236-42.
2002: Demeter Judit; Messer Gerald; Schrezenmeier Hubert
Clinical relevance of the TNF-alpha promoter/enhancer polymorphism in patients with aplastic anemia.
Annals of hematology 2002;81(10):566-9.
2002: Tichelli André; Socié Gérard; Marsh Judith; Barge Renée; Frickhofen Norbert; McCann Shaun; Bacigalupo Andrea; Hows Jill; Marin Pedro; Nachbaur David; Symeonidis Argiris; Passweg Jakob; Schrezenmeier Hubert;
Outcome of pregnancy and disease course among women with aplastic anemia treated with immunosuppression.
Annals of internal medicine 2002;137(3):164-72.
2002: Urbano-Ispizua A; Schmitz N; de Witte T; Frassoni F; Rosti G; Schrezenmeier H; Gluckman E; Friedrich W; Cordonnier C; Socie G; Tyndall A; Niethammer D; Ljungman P; Gratwohl A; Apperley J; Niederwieser D; Bacigalupo A;
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.
Bone marrow transplantation 2002;29(8):639-46.
2002: Rojewski M T; Baldus C; Knauf W; Thiel E; Schrezenmeier H
Dual effects of arsenic trioxide (As2O3) on non-acute promyelocytic leukaemia myeloid cell lines: induction of apoptosis and inhibition of proliferation.
British journal of haematology 2002;116(3):555-63.
2001: Berger F; Soligo D; Schwarz K; Bossolasco P; Schrezenmeier H; Kubanek B; Deliliers G L; Licht T
Efficient retrovirus-mediated transduction of primitive human peripheral blood progenitor cells in stroma-free suspension culture.
Gene therapy 2001;8(9):687-96.
2000: Knauf W; Fietz T; Schrezenmeier H; Thiel E
CD34 selected alloPBSCT and adoptive immunotherapy.
Bone marrow transplantation 2000;25 Suppl 2():S2-5.
2000: Griesshammer M; Kubanek B; Beneke H; Heimpel H; Bangerter M; Bergmann L; Schrezenmeier H
Serum erythropoietin and thrombopoietin levels in patients with essential thrombocythaemia.
Leukemia & lymphoma 2000;36(5-6):533-8.
2000: Bacigalupo A; Brand R; Oneto R; Bruno B; Socié G; Passweg J; Locasciulli A; Van Lint M T; Tichelli A; McCann S; Marsh J; Ljungman P; Hows J; Marin P; Schrezenmeier H
Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience.
Seminars in hematology 2000;37(1):69-80.
2000: Schrezenmeier H; Hildebrand A; Rojewski M; Häcker H; Heimpel H; Raghavachar A
Paroxysmal nocturnal haemoglobinuria: a replacement of haematopoietic tissue?
Acta haematologica 2000;103(1):41-8.
2000: Bacigalupo A; Oneto R; Bruno B; Socié G; Passweg J; Locasciulli A; Van Lint M T; Tichelli A; McCann S; Marsh J; Ljungman P; Hows J; Marin P; Schrezenmeier H
Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Blood and Marrow Transplantation.
Acta haematologica 2000;103(1):19-25.
1999: Hübinger G; Scheffrahn I; Müller E; Bai R; Duyster J; Morris S W; Schrezenmeier H; Bergmann L
The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulation.
Experimental hematology 1999;27(12):1796-805.
1999: Marsh J; Schrezenmeier H; Marin P; Ilhan O; Ljungman P; McCann S; Socie G; Tichelli A; Passweg J; Hows J; Raghavachar A; Locasciulli A; Bacigalupo A
Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.
Blood 1999;93(7):2191-5.
1999: Tichelli A; Socié G; Henry-Amar M; Marsh J; Passweg J; Schrezenmeier H; McCann S; Hows J; Ljungman P; Marin P; Raghavachar A; Locasciulli A; Gratwohl A; Bacigalupo A
Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party.
Annals of internal medicine 1999;130(3):193-201.
1998: Schrezenmeier H; Heimpel H
[Diagnosis of hemolysis and differential hemolytic anemia diagnosis]
Der Internist 1998;39(12):W1273-89.
1998: Griesshammer M; Hornkohl A; Nichol J L; Hecht T; Raghavachar A; Heimpel H; Schrezenmeier H
High levels of thrombopoietin in sera of patients with essential thrombocythemia: cause or consequence of abnormal platelet production?
Annals of hematology 1998;77(5):211-5.
1998: Schrezenmeier H; Griesshammer M; Hornkohl A; Nichol J L; Hecht T; Heimpel H; Kubanek B; Raghavachar A
Thrombopoietin serum levels in patients with aplastic anaemia: correlation with platelet count and persistent elevation in remission.
British journal of haematology 1998;100(3):571-6.
1997: Griesshammer M; Bangerter M; Schrezenmeier H
A possible role for thrombopoietin and its receptor c-mpl in the pathobiology of essential thrombocythemia.
Seminars in thrombosis and hemostasis 1997;23(5):419-23.
1996: Raghavachar A; Ganser A; Freund M; Heimpel H; Herrmann F; Schrezenmeier H
Long-term interleukin-3 and intensive immunosuppression in the treatment of aplastic anemia.
Cytokines and molecular therapy 1996;2(4):215-23.
1996: Schrezenmeier H; Jenal M; Herrmann F; Heimpel H; Raghavachar A
Quantitative analysis of cobblestone area-forming cells in bone marrow of patients with aplastic anemia by limiting dilution assay.
Blood 1996;88(12):4474-80.
1996: Späth-Schwalbe E; Schrezenmeier H; Bornstein S; Burger K; Porzsolt F; Born J
Endocrine effects of recombinant interleukin 6 in man.
Neuroendocrinology 1996;63(3):237-43.
1995: Raghavachar A; Janssen J W; Schrezenmeier H; Wagner B; Bartram C R; Schulz A S; Hein C; Cowling G; Mubarik A; Testa N G; Dexter T M; Hows J M; Marsh J C
Clonal hematopoiesis as defined by polymorphic X-linked loci occurs infrequently in aplastic anemia.
Blood 1995;86(8):2938-47.
1995: Hertenstein B; Wagner B; Bunjes D; Duncker C; Raghavachar A; Arnold R; Heimpel H; Schrezenmeier H
Emergence of CD52-, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphoma.
Blood 1995;86(4):1487-92.
1995: Späth-Schwalbe E; Schrezenmeier H; Heimpel S H
[Paroxysmal nocturnal hemoglobinuria. Clinical experiences with 40 patients at one center over 25 years]
Deutsche medizinische Wochenschrift (1946) 1995;120(30):1027-33.
1995: Schrezenmeier H; Marsh J C; Stromeyer P; Müller H; Heimpel H; Gordon-Smith E C; Raghavachar A
A phase I/II trial of recombinant human interleukin-6 in patients with aplastic anaemia.
British journal of haematology 1995;90(2):283-92.
1995: Schmid M; Schrezenmeier H; Staib G; Porzsolt F
Evidence for a paracrine pathway of B-cell stimulation in hairy cell leukaemia.
British journal of haematology 1995;90(1):156-62.
1995: Schrezenmeier H; Müller H; Gunsilius E; Heimpel H; Seifried E
Anticoagulant-induced pseudothrombocytopenia and pseudoleucocytosis.
Thrombosis and haemostasis 1995;73(3):506-13.
1995: Schrezenmeier H; Hertenstein B; Wagner B; Raghavachar A; Heimpel H
A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins.
Experimental hematology 1995;23(1):81-7.
1994: Späth-Schwalbe E; Born J; Schrezenmeier H; Bornstein S R; Stromeyer P; Drechsler S; Fehm H L; Porzsolt F
Interleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man.
The Journal of clinical endocrinology and metabolism 1994;79(4):1212-4.
1994: Schrezenmeier H; Noé G; Raghavachar A; Rich I N; Heimpel H; Kubanek B
Serum erythropoietin and serum transferrin receptor levels in aplastic anaemia.
British journal of haematology 1994;88(2):286-94.
1994: Marsh J C; Socie G; Schrezenmeier H; Tichelli A; Gluckman E; Ljungman P; McCann S R; Raghavachar A; Marin P; Hows J M
Haemopoietic growth factors in aplastic anaemia: a cautionary note. European Bone Marrow Transplant Working Party for Severe Aplastic Anaemia.
Lancet 1994;344(8916):172-3.
1994: Noé G; Schrezenmeier H; Rich I N; Kubanek B
Circulating erythropoietin levels in pathophysiological conditions.
Annals of the New York Academy of Sciences 1994;718():94-101; discussion 101-2.
1994: Funke I; Prümmer O; Schrezenmeier H; Hardt D; Weiss M; Porzsolt F; Arnold R; Heimpel H
Capillary leak syndrome associated with elevated IL-2 serum levels after allogeneic bone marrow transplantation.
Annals of hematology 1994;68(1):49-52.
1994: Porzsolt F; Schmid M; Staib G; Schrezenmeier H
Paracrine regulation of B-cell growth in hairy cell leukemia.
Leukemia & lymphoma 1994;14 Suppl 1():13-8.
1993: Schrezenmeier H; Marin P; Raghavachar A; McCann S; Hows J; Gluckman E; Nissen C; van't Veer-Korthof E T; Ljungman P; Hinterberger W
Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party.
British journal of haematology 1993;85(2):371-7.
1993: Bunjes D; Theobald M; Wiesneth M; Schrezenmeier H; Hoffmann T; Hertenstein B; Arnold R; Heimpel H
Graft rejection by a population of primed CDw52- host T cells after in vivo/ex vivo T-depleted bone marrow transplantation.
Bone marrow transplantation 1993;12(3):209-15.
1993: Schrezenmeier H; Raghavachar A; Heimpel H
Granulocyte-macrophage colony-stimulating factor in the sera of patients with aplastic anemia.
The Clinical investigator 1993;71(2):102-8.
1993: Schrezenmeier H; Thomé S D; Tewald F; Fleischer B; Raghavachar A
Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome.
Experimental hematology 1993;21(2):358-65.
1992: Schrezenmeier H; Schlander M; Raghavachar A
Cyclosporin A in aplastic anemia--report of a workshop.
Annals of hematology 1992;65(1):33-6.
1992: Kehrer H; Krone W; Schindler D; Kaufmann R; Schrezenmeier H
Cytogenetic studies of skin fibroblast cultures from a karyotypically normal female with dyskeratosis congenita.
Clinical genetics 1992;41(3):129-34.
1991: Herrmann F; Lindemann A; Lange W; Köchling G; Raghavachar A; Schrezenmeier H; Frickhofen N; Mertelsmann R H
Medullary histiocytosis following treatment of severe aplastic anemia with recombinant human interleukin-3 in combination with antilymphocyte globulin, cyclosporin A, and methylprednisolone.
Annals of hematology 1991;63(4):229-31.
1991: Frickhofen N; Kaltwasser J P; Schrezenmeier H; Raghavachar A; Vogt H G; Herrmann F; Freund M; Meusers P; Salama A; Heimpel H
Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group.
The New England journal of medicine 1991;324(19):1297-304.
1990: Anger B; Janssen J W; Schrezenmeier H; Hehlmann R; Heimpel H; Bartram C R
Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1990;4(4):258-61.
1989: Fleischer B; Schrezenmeier H; Conradt P
T lymphocyte activation by staphylococcal enterotoxins: role of class II molecules and T cell surface structures.
Cellular immunology 1989;120(1):92-101.
1988: Schrezenmeier H; Ahnert-Hilger G; Fleischer B
A T cell receptor-associated GTP-binding protein triggers T cell receptor-mediated granule exocytosis in cytotoxic T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(11):3785-90.
1988: Matthes M; Schrezenmeier H; Homfeld J; Fleischer S; Malissen B; Kirchner H; Fleischer B
Clonal analysis of human T cell activation by the Mycoplasma arthritidis mitogen (MAS).
European journal of immunology 1988;18(11):1733-7.
1988: Schrezenmeier H; Ahnert-Hilger G; Fleischer B
Inactivation of a T cell receptor-associated GTP-binding protein by antibody-induced modulation of the T cell receptor/CD3 complex.
The Journal of experimental medicine 1988;168(2):817-22.
1988: Schrezenmeier H; Fleischer B
A regulatory role for the CD4 and CD8 molecules in T cell activation.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(2):398-403.
1988: Fleischer B; Schrezenmeier H
T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells.
The Journal of experimental medicine 1988;167(5):1697-707.
1987: Schrezenmeier H; Fleischer B
Mitogenic activity of staphylococcal protein A is due to contaminating staphylococcal enterotoxins.
Journal of immunological methods 1987;105(1):133-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Hubert Schrezenmeier

Research Profile (preview)

Disorders

Chemicals & Drugs

Anatomy

Procedures

Concepts & Ideas

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Hubert Schrezenmeier (preview)

All Publications